The trial results are encouraging, with the highlight for Mainstay Medical being the 90 per cent of patients who report an improvement in quality of life after six months of using the surgically implanted device.

Anyone will chronic lower back pain will tell you just how disabling it can be. That’s why investors are excited by the prospects for a new approach b(...)

Mainstay Medical chief executive  Peter Crosby estimates that there is a potential market for its device of more than two million people in the US and Europe. Photograph: Nick Bradshaw

Irish company Mainstay Medical will seek regulatory approval in Europe for its chronic lower back pain device following clinical trial results that co(...)

The company received approval last year from the Food and Drug Administration (FDA) in the US to begin a clinical trial of its implantable neurostimulation system aimed at treating chronic low back pain

Irish medical devices firm Mainstay Medical, which agreed a debt facility of up to $15 million (€13.1 million) earlier this week, has been awarded an (...)

Peter Crosby, chief executive, Mainstay Medical. Picture: Nick Bradshaw

Medical device firm Mainstay Medical International said it has agreed a debt facility of up to $15 million (€13.1 millon). The company, which is dev(...)

Peter Crosby, CEO of  Mainstay Medical: “2014 has been a significant year for Mainstay.”  Photograph:  Nick Bradshaw

Irish medical devices firm Mainstay Medical said 2014 was a significant year for the company, as it completed a stock offering and pushed forward with(...)

Manus Rogan of Fountain Healthcare and Peter Crosby, chief executive of Mainstay Medical

CHARLIE TAYLORBack pain group Mainstay Medical, which floated in Paris and Dublin earlier this year, has said it continues to make progress with its R(...)

The bell on the decommissioned trading floor of the Irish Stock Exchange

The number of trades dealt on the Irish Stock Exchange rose by 32 per cent in the first six months of 2014.Some 2.2 million equity trades took place d(...)

Manus Rogan of Fountain Healthcare and Peter Crosby, chief executive of Mainstay Medical.

Back pain group Mainstay Medical has floated in Paris and Dublin in an IPO that values the early stage medical device company (...)

Mainstay Medical chief executive Peter Crosby.

Irish medical device company Mainstay Medical plans to raise up to €26.4 million in a stock market flotation (...)

 Peter Crosby, chief executive of Mainstay Medical. Photograph: Nick Bradshaw

Mainstay Medical, an Irish-based group focused on addressing chronic back pain, has announced it plans to float on the (...)